A Phase II Randomized, Double-Blind, Placebo Controlled Study of the Clinical Effectiveness of a Human Monoclonal Antibody to Clostridium difficile Toxin A [GS-CDA1] and a Human Monoclonal Antibody to

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science